Plain-English translation of NCT06118788 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help patients whose acute myeloid leukemia (a serious blood cancer) has returned or is no longer responding to standard treatments. The study will start by giving patients small doses of the medication and gradually increase the dose to find the safest and most effective level. Researchers will then give more patients that dose level to confirm it works and continues to be safe.
Acute myeloid leukemia that comes back or stops responding to treatment is very difficult to cure with existing therapies, and patients urgently need new options. This trial is testing whether this new medication might offer hope by targeting leukemia cells in a different way.
You likely qualify if…
You likely don't qualify if…
The trial has two phases. First, researchers will enroll 12–18 patients and slowly increase the dose of the injection to find the safest level and the dose that works best. Then, if that dose shows promise, they will enroll additional patients to receive that same dose and monitor them carefully for safety and how well the treatment works. Throughout the study, you will have regular visits for blood tests, scans, and check-ups to see how you are doing.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China